Director at the Mayo Clinic and Mayo Clinic Laboratories In Rochester, Minnesota; Associate Professor of Medicine and Laboratory Medicine, Mayo Clinic College of Medicine and Science
BIOGRAPHY
JUN 07, 2022 10:00 AM PDT
New 2021 CDC HIV PrEP (Preexposure Prophylaxis) Guidelines: Implications for Clinicians and Laboratories
Speaker
Event Date & Time
Date: June 07, 2022
Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST)
Abstract
On December 8th, 2021 the CDC released new recommendations for preexposure prophylaxis (PrEP) for the prevention of HIV infection in the US. These new guidelines include important updates designed to help increase access to and awareness of PrEP as well as new recommendations for laboratory testing. This webinar will review these important changes and discuss how they will impact patients, clinicians, and the clinical laboratories providing results that play a critical role in this updated approach.
Learning Objectives
- Outline current HIV/PrEP landscape in the US
- Describe important changes in the new 2021 CDC PrEP Guidelines
- Review rationale of new recommendations for NAAT in PrEP monitoring and potential impact on clinical laboratories, clinicians, and patients
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 05, 2025 | 1:00 PM
C.E. CREDITS
Explore the evolution, methods, and limitations of mixing studies in detecting factor deficiencies and lupus anticoagulants in coagulation testing....
DEC 09, 2025 | 10:00 AM
Antibody-drug conjugates (ADCs) are transforming oncology by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. Yet, developing effective ADCs requires ove...
DEC 09, 2025 | 10:00 AM
Ensuring quality and compliance is at the core of every successful clinical laboratory. This webinar brings together CAP expert Daniel and Christie, QA leader from Burning Rock, to explore t...
DEC 10, 2025 | 2:00 PM
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...
DEC 10, 2025 | 8:00 AM
Mass spectrometry (MS)-based proteomic biomarker discovery pipeline commonly begins with large-scale profiling techniques detecting thousands of candidate biomarkers. Efficiently triaging th...
DEC 10, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...
Loading Comments...